Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/21/14  and contains information from public web pages and contributions from the ZoomInfo community.

Christopher J. Smalley

Wrong Christopher J. Smalley?

Associate Director

Local Address: Georgia, United States
Merck & Co. , Inc.
One Merck Dr Po Box 100 Ws3Ab-05
Whitehouse Station, New Jersey 08889
United States

Company Description: Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human...   more
Background

Employment History

  • Position, Vaccine and Pharmaceutical Businesses of the Organization
    Merck & Co. , Inc.
  • Director, Engineering BioSterile Validation
    Merck & Co. , Inc.
  • Associate Director
    BioSterile Validation
  • Director of Quality Operations
    Wyeth
  • Director, Compliance Operations
    Wyeth
  • Plant Manager
    Janssen Pharmaceutica
  • the United States Air Force

Board Memberships and Affiliations

Education

  • Philadelphia College of Pharmacy of the University of the Sciences
  • Masters of Science , Pharmaceutical Chemistry
    Temple University School of Pharmacy
  • MBA
    Temple University Fox School of Business
  • PhD
30 Total References
Web References
Christopher ...
www.pda.org, 21 Aug 2014 [cached]
Christopher Smalley
...
Christopher Smalley, PhD Merck & Co.
Co., Ltd. and ...
www.pda.org, 21 Aug 2014 [cached]
Co., Ltd. and Christopher Smalley, PhD, Associate Director, Merck & Company.
Christina's current position ...
pdaannualmeeting.org, 3 July 2014 [cached]
Christina's current position is the Director of Research and Human Factors at Radius Product Development where her primary role is to provide technical oversight to the research and HF teams and champion the integration of human factors in the product development process. In this role, she has contributed technical expertise to a number of projects ranging from large scale medical devices, bioprocessing and manufacturing, to systems and consumer goods. She is an expert at translating research findings such as user needs, requirements, product strengths and product weaknesses into compelling design directions and solutions. At the heart of her skill set are human factors and ergonomics where she has carried out numerous User-Centered Risk Analyses, HF/E Evaluations and Competitive Benchmarks while taking great pride in maintaining the integrity of sound HF/E guidelines and standards throughout the development process.
She brings over a decade of experience in usability testing and user research experience having conducted more than 1000 one-on-one sessions in various product domains and user environments in both the U.S. and internationally. At the heart of Christina's skill set are human factors and ergonomics where she has carried out numerous HF/E evaluations and competitive benchmarks and takes great pride in maintaining the integrity of sound HF/E guidelines and standards throughout the various stages of the design process. A great deal of her training was in research methodologies and statistical analyses which she leverages in the majority of her work.
...
Chris Smalley has recently joined Merck where he has responsibility for innovative processes and biotechnology implementation and validation and single-use-systems worldwide in the vaccine and pharmaceutical businesses of the organization. Previously, he had been the Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and conducting validation activities globally in the pharmaceutical, biotechnology, consumer health and nutritional businesses. His research experience includes responsibility for Quality in the United States operations of the Sanofi Research Division. He has also worked for the Johnson & Johnson, where he was the Plant Manager for the Parenterals facility for Janssen Pharmaceutical. Chris retired from the United States Air Force as a Lt. Col where he practiced as a pharmacist and healthcare administrator and is a graduate of the Philadelphia College of Pharmacy of the University of the Sciences in Philadelphia, Pa. His graduate education includes a MBA from Temple University Fox School of Business and a Masters of Science in Pharmaceutical Chemistry from Temple University School of Pharmacy. He has performed post-graduate work with the United States Navy at the Monterey, Calif. Post-Graduate School.
Chris is currently a member of the PDA Board of Directors as well as a member of the Science Advisory Board.
Root causes of the problems in ...
www.ipqpubs.com, 12 April 2014 [cached]
Root causes of the problems in the pharmacy compounding arena range from the absence of training in pharmacy schools to commercial pressures that prompt established pharmaceutical firms to leave the market and force hospitals to rely on less qualified providers to fill their immediate patient needs, Merck Engineering BioSterile Validation Director Chris Smalley commented at the April PDA annual meeting held in San Antonio, Texas.
Smalley's insightful analysis of the current high-profile issues in the compounding arena was informed by both his extensive pharma experience as well as by the first two decades of his career, which was spent in the U.S. military as a licensed pharmacist performing hospital compounding.
As a hospital pharmacist, Smalley prepared IVs and total parenteral nutritional (TPN) packages. He explained that his training in pharmacy school in the 1970's included laboratory courses that taught various types of compounding and evaluated the student's ability to perform them.
"I couldn't pass compounding lab until I could make capsules," Smalley commented. "We made suppositories. We made powder…. And we made sterile products," including hand-filling ampules with syringes. "I learned about aseptic technique."
Over the intervening three decades, the pharmacy school curriculum has shifted towards clinical pharmacy - focused on drug/patient issues - and hands-on pharmacy compounding is no longer usually taught, Smalley pointed out.
Science Advisory Board (SAB) - Parenteral Drug Association
www.pda.org, 21 Dec 2013 [cached]
Christopher J. Smalley, Ph.D. Associate Director, BioSterile Validation Merck & Co., Inc.
Other People with the name "Smalley":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304